Bernhard Hoffmann - 10 Jan 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: SVP of Corp. Dev. & Ops & Sec.
Signature: /s/ Emily J. Johns, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 10 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 12 Jan 2023, 16:33:57 UTC
Previous filing: 01 Feb 2022
Next filing: 12 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+46,608	+47%	$0.000000	146,728	10 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+69,912		$0.000000	69,912	10 Jan 2023	Common Stock	69,912	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
F2	The option will vest with respect to 17,478 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.